Clinical trial: 89 Zr TLX250 Immuno-PET Cohort
OPALESCENCE : 89 Zr TLX250 Immuno-PET Cohort Type of study : Single-centre study Pathology : Metastatic triple negative breast cancer
Clinical trial: EITHICS protocol
EITHICS protocol: Study of inflammation using 18F DPA714 PET Type of study: Multicentre study Pathology: Triple-negative breast cancer, operated on
Clinical trial: FICTIoN Cohort
FICTIoN Cohort: Radiomic analyses of 18FDG PET and correlation with histology Type of study: Single-centre study Pathology: Triple-negative breast cancer,
Clinical trial: EPICURE cohort
EPICURE Cohort: Characterisation of tumour heterogeneity using Radiomics Type of study: Single-centre study Pathology: Breast cancer in first metastatic recurrence
Clinical trial: 18FES PET protocol
Predicting the effectiveness of second-line metastatic hormone therapy Type of study: Multicentre study Pathology: Metastatic breast cancer, HER2 negative Investigatr
Clinical trial: immuno-PET optimization protocol
Immuno-PET optimization protocol: anti-ACE pre-targeting Type of study: Feasibility study Pathology: HER2 negative, ACE positive metastatic breast cancer Investigator :
